GT Biopharma, Inc.GTBPNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank43
Year-over-Year Change
Profit from core business operations before interest and taxes
Latest
$-12.42M
↑ 77% vs avg
Percentile
P43
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-53.24M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-12.42M | +13.5% |
| 2024 | $-14.36M | -5.8% |
| 2023 | $-13.58M | +36.1% |
| 2022 | $-21.26M | +63.0% |
| 2021 | $-57.52M | -750.3% |
| 2020 | $-6.76M | +41.0% |
| 2019 | $-11.46M | +95.4% |
| 2018 | $-250.07M | -84.5% |
| 2017 | $-135.57M | -1346.2% |
| 2016 | $-9.37M | - |